These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3147121)
1. Transport of [3H]mazindol binding sites in mesostriatal dopamine axons. O'Dell SJ; Marshall JF Brain Res; 1988 Sep; 460(2):402-6. PubMed ID: 3147121 [TBL] [Abstract][Full Text] [Related]
2. The effects of serotonergic and dopaminergic lesions on sodium-sensitive [3H]mazindol binding in rat hypothalamus and corpus striatum. Angel I; Janowsky A; Paul SM Brain Res; 1989 Dec; 503(2):339-41. PubMed ID: 2514010 [TBL] [Abstract][Full Text] [Related]
3. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. I. Effects of intranigral or intracerebroventricular 6-hydroxydopamine lesions of the mesostriatal dopamine system. Joyce JN Exp Neurol; 1991 Sep; 113(3):261-76. PubMed ID: 1833219 [TBL] [Abstract][Full Text] [Related]
4. [3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Javitch JA; Blaustein RO; Snyder SH Mol Pharmacol; 1984 Jul; 26(1):35-44. PubMed ID: 6087116 [TBL] [Abstract][Full Text] [Related]
5. Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiography. Javitch JA; Strittmatter SM; Snyder SH J Neurosci; 1985 Jun; 5(6):1513-21. PubMed ID: 4009243 [TBL] [Abstract][Full Text] [Related]
6. Chronic eticlopride and dopamine denervation induce equal nonadditive increases in striatal D2 receptor density: autoradiographic evidence against the dual mechanism hypothesis. LaHoste GJ; Marshall JF Neuroscience; 1991; 41(2-3):473-81. PubMed ID: 1678501 [TBL] [Abstract][Full Text] [Related]
7. Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats. Berger K; Przedborski S; Cadet JL Brain Res Bull; 1991 Feb; 26(2):301-7. PubMed ID: 1826461 [TBL] [Abstract][Full Text] [Related]
8. Differential response of striatal dopamine and muscarinic cholinergic receptor subtypes to the loss of dopamine. II. Effects of 6-hydroxydopamine or colchicine microinjections into the VTA or reserpine treatment. Joyce JN Exp Neurol; 1991 Sep; 113(3):277-90. PubMed ID: 1833220 [TBL] [Abstract][Full Text] [Related]
9. Catecholamine uptake sites in mouse brain: distribution determined by quantitative [3H]mazindol autoradiography. Donnan GA; Kaczmarczyk SJ; McKenzie JS; Kalnins RM; Chilco PJ; Mendelsohn FA Brain Res; 1989 Dec; 504(1):64-71. PubMed ID: 2598017 [TBL] [Abstract][Full Text] [Related]
10. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum. Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609 [TBL] [Abstract][Full Text] [Related]
11. Comparative development of D1-dopamine and mu opiate receptors in normal and in 6-hydroxydopamine-lesioned neonatal rat striatum: dopaminergic fibers regulate mu but not D1 receptor distribution. Caboche J; Rogard M; Besson MJ Brain Res Dev Brain Res; 1991 Jan; 58(1):111-22. PubMed ID: 1849802 [TBL] [Abstract][Full Text] [Related]
13. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Chinaglia G; Alvarez FJ; Probst A; Palacios JM Neuroscience; 1992 Jul; 49(2):317-27. PubMed ID: 1436470 [TBL] [Abstract][Full Text] [Related]
14. Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Graham WC; Crossman AR; Woodruff GN Brain Res; 1990 Apr; 514(1):93-102. PubMed ID: 2113410 [TBL] [Abstract][Full Text] [Related]
15. [3H]GBR-12935 binding to dopamine uptake sites in rat striatum. Allard PO; Eriksson K; Ross SB; Marcusson JO Neuropsychobiology; 1990-1991; 23(4):177-81. PubMed ID: 2130286 [TBL] [Abstract][Full Text] [Related]
16. Localization of striatal and nigral tachykinin receptors in the rat. Stoessl AJ Brain Res; 1994 May; 646(1):13-8. PubMed ID: 7519961 [TBL] [Abstract][Full Text] [Related]
17. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes. Dubocovich ML; Zahniser NR Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318 [TBL] [Abstract][Full Text] [Related]
18. Non-additivity of D2 receptor proliferation induced by dopamine denervation and chronic selective antagonist administration: evidence from quantitative autoradiography indicates a single mechanism of action. LaHoste GJ; Marshall JF Brain Res; 1989 Nov; 502(2):223-32. PubMed ID: 2531015 [TBL] [Abstract][Full Text] [Related]
19. [3H]tyramine binding: a comparison with neuronal [3H]dopamine uptake and [3H]mazindol binding processes. Vaccari A; Gessa G Neurochem Res; 1989 Oct; 14(10):949-55. PubMed ID: 2532713 [TBL] [Abstract][Full Text] [Related]
20. Substantia nigra 6-hydroxydopamine lesions alter dopaminergic synaptic markers in the nucleus basalis magnocellularis and striatum of rats. Geula C; Slevin JT Synapse; 1989; 4(3):248-53. PubMed ID: 2532792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]